Differential roles of the tandem C1 domains of protein kinase C δ in the biphasic down-regulation induced by bryostatin 1

Cancer Research

Volumn 59, Issue 24, 1999, Pages 6137-6144

  Lorenzo, Patricia S ^a   Bögi, Krisztina ^a   Hughes, Kathleen M ^a   Beheshti, Maryam ^a   Bhattacharyya, Dipak ^a   Garfield, Susan H ^a   Pettit, George R ^b   Blumberg, Peter M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRYOSTATIN 1; GREEN FLUORESCENT PROTEIN; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; GENE CONTROL; GENE OVEREXPRESSION; GENE TRANSLOCATION; LIGAND BINDING; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION;

3T3 CELLS; ANIMALS; ANTINEOPLASTIC AGENTS; BINDING SITES; DOWN-REGULATION; ISOENZYMES; LACTONES; LIGANDS; MACROLIDES; MICE; MUTAGENESIS, SITE-DIRECTED; PHORBOL 12,13-DIBUTYRATE; PROTEIN CONFORMATION; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; TRITIUM;

EID: 0343819883     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Pettit, G. R., Herald, C. L., Doubek, D. L., Herald, D. L., Arnold, E., and Clardy, J. Isolation and structure of bryostatin 1. J. Am. Chem. Soc., 104: 6846-6848, 1982.
2. Blumberg, P. M., and Pettit, G. R. The bryostatins, a family of protein kinase C activators with therapeutic potential. In: P. Krosgaard-Larsen, C. Brogger Christensen, and H. Kodof (eds.), New Leads and Targets in Drug Research, pp. 273-285. Copenhagen: Munksgaard International Publishers, 1992.
3. Grant, S., and Jarvis, W. D. Modulation of drug-induced apoptosis by interruption of the protein kinase C signal transduction pathway: a new therapeutic strategy. Clin. Cancer Res., 2: 1915-1920, 1996.
4. Hocevar, B. A., Morrow, D. M., Tykocinsky, M. L., and Fields, A. P. Protein kinase C isotypes in human erythroleukemia cell proliferation and differentiation. J. Cell Sci., 101: 671-679, 1992.
5. Kennedy, M. J., Prestigiacomo, L. J., Tyler, G., May, W. S., and Davidson, N. E. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines. Cancer Res., 52: 1278-1283, 1992.
6. Jaken, S. Protein kinase C and tumor promoters. Curr. Opin. Cell. Biol., 2: 192-197, 1990.
7. Newton, A. C. Protein kinase C: structure, function and regulation. J. Biol. Chem., 270: 28495-28497, 1995.
8. Parker, P. J., Kour, G., Marais, R. M., Mitchell, F., Pears, C., Schaap, D., Stabel, S., and Webster, C. Protein kinase C: a family affair. Mol. Cell. Endocrinol., 65: 1-11, 1989.
9. Hug, H., and Sane, T. F. Protein kinase C isoenzymes: divergence in signal transduction? Biochem. J., 291: 329-343, 1993.
10. Ono, Y., Fujii, T., Igarashi, K., Kuno, T., Tanaka, C., Kikkawa, U., and Nishizuka, Y. Phorbol ester binding to protein kinase C requires a cysteine-rich zinc finger-like sequence. Proc. Natl. Acad. Sci. USA, 86: 4868-4871, 1989.
11. Burns, D. J., and Bell, R. M. Protein kinase C contains two phorbol ester binding domains. J. Biol. Chem., 266: 18330-18338, 1991.
12. Hurley, J. H., Newton, A. C., Parker, P. J., Blumberg, P. M., and Nishizuka, Y. Taxonomy and function of CI protein kinase C homology domains. Protein Sci., 6: 477-480, 1997.
13. 3H]bryostatin 1 and analogs to calcium-dependent and calcium-independent protein kinase C isozymes. Mol. Pharmacol., 46: 374-379, 1994.
14. Szallasi, Z., Smith, L., Pettit, G. R., and Blumberg, P. M. Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. J. Biol. Chem., 269: 2118-2124, 1994,
15. Szallasi, Z., Denning, M. F., Smith, C. B., Dlugosz, A. A., Yuspa, S. H., Pettit, G. R., and Blumberg, P. M. Bryostatin 1 protects protein kinase C-δ from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation. Mol. Pharmacol., 46: 840-850, 1994.
16. Lee, H-W., Smith, L., Pettit, G. R., and Bingham-Smith, J. B. Dephosphorylation of activated protein kinase C contributes to downregulation by bryostatin 1. Am. J. Physiol., 271: C304-C311, 1996.
17. Isakov, N., Galron, D., Mustelin, T., Pettit, G. R., and Altman, A. Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase C. J. Immunol., 150: 1195-1204, 1993.
18. Szallasi, Z., Du, L., Levine, R., Lewin, N. E., Nguyen, P. N., Williams, M. D., Pettit, G. R., and Blumberg, P. M. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-dependent mechanism: dissociation of activities using 16-epi-bryostatin 1. Cancer Res., 56: 2105-2111, 1996.
19. Basu, A., and Akkaraju, G. R. Regulation of caspase activation and cis-diamminedichloroplatinum(II)-induced cell death by protein kinase C. Biochemistry, 38: 4245-4251, 1999.
20. Lorenzo, P. S., Bögi, K., Acs, P., Pettit, G. R., and Blumberg, P. M. The catalytic domain of protein kinase Cδ confers protection from down-regulation induced by bryostatin 1. J. Biol. Chem., 272: 33338-33343, 1997.
21. Szallasi, Z., Bögi, K., Gohari, S., Biro, T., Acs, P., and Blumberg, P. M. Non-equivalent roles for the first and the second zinc fingers of protein kinase C δ. Effect of their mutation on phorbol ester-induced translocation in NIH 3T3 cells. J. Biol. Chem., 271: 18299-18301, 1996.
22. Oláh, Z., Lehel, C., Jakab, G., and Anderson, W. B. A cloning and ∈-epitope-tagging insert for the expression of polymerase chain reaction-generated cDNA fragments in Escherichia coli and mammalian cells. Anal. Biochem., 221: 94-102, 1994.
23. Kazanietz, M. G., Areces, L. B., Bahador, A., Mischak, H., Goodnight, J., Mushinski, J. F., and Blumberg, P. M. Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase C. Mol. Pharmacol., 44: 298-307, 1993.
24. 3H]phorbol 12,13-dibutyrate binding. Cancer Res., 45: 19-24, 1985.
25. 3H]bryostatin 4 to protein kinase C. Biochem. Pharmacol., 43: 2007-2014, 1992.
26. Wang, S., Liu, M., Lewin, N. E., Lorenzo, P. S., Bhattacharyya, D., Qiao, L., Kozikowski, A., Milne, G. W. A., and Blumberg, P. M. Probing the binding of indolactam-V to protein kinase C through site directed mutagenesis and computational docking simulations. J. Med. Chem., 42: 3436-3446, 1999.
27. Bögi, K., Lorenzo, P. S., Szallasi, Z., Acs, P., Wagner, G., and Blumberg, P. M. Differential selectivity of ligands for the C1a and C1b phorbol ester binding domains of protein kinase Cδ: possible correlation with tumor-promoting activity. Cancer Res., 58: 1423-1428, 1998.
28. Oancea, E., and Meyer, T. Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals. Cell, 95: 307-318, 1998.
29. Sakai, N., Sasaki, K., Ikegaki, N., Shirai, Y., Ono, Y., and Saito, N. Direct visualization of the translocation of the γ-subspecies of protein kinase C in living cells using fusion proteins with green fluorescent protein. J. Cell. Biol., 139: 1465-1476, 1997.
30. Ohmori, S., Shirai, Y., Sakai, N., Fujii, M., Konishi, H., Kikkawa, U., and Saito, N. Three distinct mechanisms for translocation and activation of the δ subspecies of protein kinase C. Mol. Cell. Biol., 18: 5263-5271, 1998.
31. Shieh, H. L., Hansen, H., Zhu, J., and Riedel, H. Activation of conventional mammalian protein kinase C isoforms expressed in budding yeast modulates the cell doubling time: a potential in vivo screen for protein kinase C activators. Cancer Detect. Prev., 20: 576-589, 1996.
32. Slater, S. J., Ho, C., Kelly, M. B., Larkin, J. D., Taddeo, F. J., Yeager, M. D., and Stubbs, C. D. Protein kinase C α contains two activator binding sites that bind phorbol esters and diacylglycerol with opposite affinities. J. Biol. Chem., 271: 4627-4631, 1996.
33. Emoto, Y., Manome, Y., Meinhardt, G., Kisaki, H., Kharbanda, S., Robertson, M., Ghayur, T., Wong, W. W., Kamen, R., Weichselbaum, R., and Kufe, D. Proteolytic activation of protein kinase C δ by an ICE-like protease in apoptotic cells. EMBO J., 14: 6148-6156, 1995.
34. Ghayur, T., Hugunin, M., Talanian, R., Ratnofsky, S., Quinlan, C., Emoto, Y., Pandey, P., Datta, R., Huang, Y., Kharbanda, S., Allen, H., Kamen, R., Wong, W., and Kufe, D. Proteolytic activation of protein kinase C δ by an ICE/CED 3-like protease induces characteristics of apoptosis. J. Exp. Med., 184: 2399-2404, 1996.
35. Lu, Z., Liu, D., Hernia, A., Devonish, W., Pagano, W., and Foster, D. A. Activation of protein kinase C triggers its ubiquitination and degradation. Mol. Cell. Biol., 18: 839-845, 1998.
36. Lee, H. W., Smith, L., Pettit, G. R., and Smith, L. B. Bryostatin 1 and phorbol ester down-modulate protein kinase C-α and -∈ via the ubiquitin/proteosome pathway in human fibroblasts., Mol. Pharmacol. 51: 439-447, 1997.
37. Lee, H. W., Smith, L., Pettit, G. R., Vinitsky, A., and Smith, J. B. Ubiquitination of protein kinase C-α and degradation by the proteasome. J. Biol. Chem., 271: 20973-20976, 1996.
38. Szallasi, Z., Kosa, K., Smith, C. B., Dlugosz, A. A., Williams, E. K., Yuspa, S. H., and Blumberg, P. M. Differential regulation by anti-tumor-promoting 12-deoxyphorbol-13-phenylacetate reveals distinct roles of the classical and novel protein kinase C isozymes in biological responses of primary mouse keratinocytes. Mol. Pharmacol., 47: 258-265, 1995.
39. Keranen, L. M., Dutil, E. M., and Newton, A. C. Protein kinase C is regulated in vitro by three functionally distinct phosphorylations. Curr. Biol., 5: 1394-1403, 1995.
40. Quest, A. F. Regulation of protein kinase C: a tale of lipids and proteins. Enzyme Protein, 49: 231-261, 1996.
41. Mochly-Rosen, D., and Gordon, A. S. Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J., 12: 35-42, 1998.